Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,215
datasets available to search
ShareScore release 0.9.0
Dataset results
4,215 results for “high risk”
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
ClinicalTrials.gov study NCT01240902. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
ClinicalTrials.gov study NCT04995029. IPD Sharing: NO. Countries: 2. Publications: 3.
Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01555541. IPD Sharing: NO. Countries: 1. Publications: 1.
Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery
ClinicalTrials.gov study NCT00888940. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism
ClinicalTrials.gov study NCT03044574. IPD Sharing: NO. Countries: 1. Publications: 2.
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
ClinicalTrials.gov study NCT00282087. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
ClinicalTrials.gov study NCT02113878. IPD Sharing: NO. Countries: 1. Publications: 1.
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
ClinicalTrials.gov study NCT03322267. IPD Sharing: NO. Countries: 1. Publications: 1.
Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With The
ClinicalTrials.gov study NCT03415178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
ClinicalTrials.gov study NCT00088218. IPD Sharing: Not stated. Countries: 1. Publications: 1.
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01038635. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
ClinicalTrials.gov study NCT02196857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03969004. IPD Sharing: YES. Countries: 16. Publications: 1.
Screen-and-treat Program for Chronic Kidney Disease- High Risk Persons
ClinicalTrials.gov study NCT02059408. IPD Sharing: NO. Countries: 1. Publications: 5.
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
ClinicalTrials.gov study NCT00876915. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT01869114. IPD Sharing: Not stated. Countries: 1. Publications: 39.
Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events
ClinicalTrials.gov study NCT04271280. IPD Sharing: NO. Countries: 14. Publications: 3.
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
ClinicalTrials.gov study NCT05712200. IPD Sharing: YES. Countries: 34. Publications: 0.
A TargEted MAnageMent Intervention for Reducing Stroke Risk Factors in High Risk Ugandans
ClinicalTrials.gov study NCT04685408. IPD Sharing: YES. Countries: 1. Publications: 2.
Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01893320. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.